Carcinoma Non-small-cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Carcinoma Non-small-cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2022-11-24EMA Application withdrawn: Exkivity (mobocertinib) — Takeda Pharma A/S
The EMA has withdrawn the application for Exkivity (mobocertinib) by Takeda Pharma A/S.